2010
CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT. CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Research & Therapy 2010, 12: r14. PMID: 20102624, PMCID: PMC2875642, DOI: 10.1186/ar2915.Peer-Reviewed Original ResearchConceptsCD16 expressionOC precursorsInflammatory arthritisHealthy controlsMethodsPeripheral blood mononuclear cellsNuclear factor kappa-B ligandCD16-positive monocytesSubset of CD14Chronic inflammatory arthritisBlood mononuclear cellsHuman peripheral bloodCD16 surface expressionColony-stimulating factorPsA patientsPsoriatic arthritisBone erosionDendritic cellsPsoriasis subjectsMononuclear cellsPeripheral bloodTumor necrosisCD16Receptor activatorBone wafersArthritis
2008
Altered bone remodeling in psoriatic arthritis
Mensah KA, Schwarz EM, Ritchlin CT. Altered bone remodeling in psoriatic arthritis. Current Rheumatology Reports 2008, 10: 311-317. PMID: 18662512, PMCID: PMC2656567, DOI: 10.1007/s11926-008-0050-5.Peer-Reviewed Original ResearchConceptsPsoriatic arthritisTumor necrosis factor inhibitionInflammatory joint diseaseNecrosis factor inhibitionBasic science findingsInflammatory arthritisNew bone formationBone resorptionFactor inhibitionJoint diseaseBone homeostasisArthritisBone formationAltered boneSkeletal systemBone biologyDynamic organClinical applicationPivotal roleRecent studiesBoneOsteoimmunologyScience findings